STOCK HOLDERS' EQUITY (Details)	9 Months Ended		134 Months Ended				1 Months Ended	3 Months Ended			3 Months Ended			0 Months Ended					9 Months Ended
	May 31, 2013 USD ($)	May 31, 2012 USD ($)	May 31, 2013 USD ($)	Jan. 23, 2013	Jan. 22, 2013	Aug. 31, 2012	Sep. 30, 2012 Securities Purchase Agreement [Member]	Nov. 30, 2012 Securities Purchase Agreement [Member] USD ($)	Nov. 30, 2012 Leading Investor [Member]	Sep. 30, 2012 Leading Investor [Member]	Nov. 30, 2012 Other Individual [Member] USD ($)	Sep. 30, 2012 Other Individual [Member]	Sep. 30, 2012 Dr. Michael Berelowitz M.D. [Member]	Mar. 05, 2013 D.N.A. [Member] USD ($)	Mar. 05, 2013 D.N.A. [Member] ILS	Feb. 14, 2013 D.N.A. [Member] USD ($)	Feb. 14, 2013 D.N.A. [Member] ILS	Oct. 30, 2012 D.N.A. [Member] USD ($)	May 31, 2013 D.N.A. [Member]	Mar. 31, 2011 D.N.A. [Member]
Stockholders' Equity [Line Items]
Common stock issued							5,652				1,127							199,172
Number of shares authorized by warrant							2,826					564	6,373
Securities Purchase Agreements, number of units								329,832	405,405
Proceeds from issuance of shares	$ 1,450,936		$ 16,595,571					$ 1,464,425			$ 12,885
Securities Purchase Agreements, number of shares per unit								1
Securities Purchase Agreements, number of shares per warrant								0.50
Securities Purchase Agreements, number of warrants per unit								1
Warrant term								5 years
Exercise price per share							6.00
Service agreement consideration																		628,630
Securities Purchase Agreements, purchase price per unit								$ 4.44
Option to purchase shares of D.N.A																		21,637,611
Stock sold														3,500,000	3,500,000	3,500,000	3,500,000
Cash proceed from sale of stock														$ 112,540	420,000	$ 114,130	420,000
Percentage of stock owned																			11.10%
Percent of shares owned by investor										5.00%
Number of D.N.A. shares owned																				8,404,667
Reverse stock split ratio	12
Common shares issued	7,226,423		7,226,423	7,200,000	86,500,000	6,674,068
Common shares outstanding	7,226,423		7,226,423	7,200,000	86,500,000	6,674,068
Common shares authorized	16,666,667		16,666,667	16,700,000	200,000,000	16,666,667